NCT06427642View on ClinicalTrials.gov

Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

May 30, 2024

Study Completion Date

April 30, 2025

Conditions
Hypoxic-Ischemic EncephalopathyBronchopulmonary DysplasiaShort Bowel Syndrome
Interventions
BIOLOGICAL

Mononuclear cells

UCB-MNCs are obtained from umbilical cord blood by density gradient centrifugation

DEVICE

Mild hypothermia therapy

Mild hypothermia therapy via hypothermia therapy apparatus

DEVICE

Breathing support technique

Breathing support via ventilator

PROCEDURE

Total parenteral nutrition

Liquid nutrition injected directly into the bloodstream

Trial Locations (1)

Unknown

RECRUITING

Qilu Children's Hospital of Shandong University, Jinan

All Listed Sponsors
collaborator

Qilu Children's Hospital of Shandong University

OTHER

lead

Shandong Qilu Stem Cells Engineering Co., Ltd.

INDUSTRY